BackIR-Med Overview
IR-Med Inc.

IR-Med Return on Equity

IR-Med (IRME) has a ROE of 376.0%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

376.00%

Return on Equity

376.00%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

IR-Med (IRME) FAQ

The latest ROE for IRME is 376.0%. That is above the sector sector average of 11.3%. Investors often review this figure alongside IR-Med's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, IRME currently prints 376.0% for ROE, while the sector average sits near 11.3%. That is roughly 3228.6% above the sector mean. Large gaps often invite a closer look at IR-Med's growth, margins, and balance sheet.

Return on Equity shows how effectively IR-Med converts resources into returns. At 376.0%, IRME may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IRME's ROE (376.0%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.